Lübbert M - Search Results

1

Gene expression analysis of decitabine treated AML: high impact of tumor suppressor gene expression changes.

Bohl SR, Dolnik A, Jensen T, Lang KM, Hackanson B, Gaidzik VI, Paschka P, Knudsen S, Döhner K, Döhner H, Claus R, Lübbert M, Bullinger L. Bohl SR, et al. Among authors: lubbert m. Leuk Lymphoma. 2017 Sep;58(9):1-4. doi: 10.1080/10428194.2017.1287360. Epub 2017 Feb 13. Leuk Lymphoma. 2017. PMID: 28278722 No abstract available.

2

Mechanisms of p53 alteration in acute leukemias.

Schottelius A, Brennscheidt U, Ludwig WD, Mertelsmann RH, Herrmann F, Lübbert M. Schottelius A, et al. Among authors: lubbert m. Leukemia. 1994 Oct;8(10):1673-81. Leukemia. 1994. PMID: 7523798

3

N-RAS gene activation in acute myeloid leukemia: association with expression of interleukin-6.

Lübbert M, Oster W, Knopf HP, McCormick F, Mertelsmann R, Herrmann F. Lübbert M, et al. Leukemia. 1993 Dec;7(12):1948-54. Leukemia. 1993. PMID: 8255093

4

Successful treatment of disseminated central nervous aspergillosis in a patient with acute myeloblastic leukemia.

Mahlknecht U, von Lintig F, Mertelsmann R, Lindemann A, Lübbert M. Mahlknecht U, et al. Among authors: lubbert m. Leuk Lymphoma. 1997 Sep;27(1-2):191-4. doi: 10.3109/10428199709068287. Leuk Lymphoma. 1997. PMID: 9373212

5

Epigenetic targets in hematopoietic malignancies.

Claus R, Lübbert M. Claus R, et al. Among authors: lubbert m. Oncogene. 2003 Sep 29;22(42):6489-96. doi: 10.1038/sj.onc.1206814. Oncogene. 2003. PMID: 14528273 Review.

6

Induction of gene expression by 5-Aza-2'-deoxycytidine in acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS) but not epithelial cells by DNA-methylation-dependent and -independent mechanisms.

Schmelz K, Sattler N, Wagner M, Lübbert M, Dörken B, Tamm I. Schmelz K, et al. Among authors: lubbert m. Leukemia. 2005 Jan;19(1):103-11. doi: 10.1038/sj.leu.2403552. Leukemia. 2005. PMID: 15510208

7

The silence of the genes: epigenetic disturbances in haematopoietic malignancies.

Hackanson B, Guo Y, Lübbert M. Hackanson B, et al. Among authors: lubbert m. Expert Opin Ther Targets. 2005 Feb;9(1):45-61. doi: 10.1517/14728222.9.1.45. Expert Opin Ther Targets. 2005. PMID: 15757481 Review.

8

Characterization of DNA demethylation effects induced by 5-Aza-2'-deoxycytidine in patients with myelodysplastic syndrome.

Mund C, Hackanson B, Stresemann C, Lübbert M, Lyko F. Mund C, et al. Among authors: lubbert m. Cancer Res. 2005 Aug 15;65(16):7086-90. doi: 10.1158/0008-5472.CAN-05-0695. Cancer Res. 2005. PMID: 16103056

9

Treatment of myelodysplastic syndrome with a DNA methyltransferase inhibitor: lack of evidence for induction of chromosomal instability.

Haas PS, Wijermans P, Verhoef G, Lübbert M. Haas PS, et al. Among authors: lubbert m. Leuk Res. 2006 Mar;30(3):338-42. doi: 10.1016/j.leukres.2005.07.014. Epub 2005 Sep 12. Leuk Res. 2006. PMID: 16162357 Clinical Trial.

10

Epigenetic treatment of hematopoietic malignancies: in vivo targets of demethylating agents.

Claus R, Almstedt M, Lübbert M. Claus R, et al. Among authors: lubbert m. Semin Oncol. 2005 Oct;32(5):511-20. doi: 10.1053/j.seminoncol.2005.07.024. Semin Oncol. 2005. PMID: 16210092 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

368 results

Search Page

Filters